Trimethoprim is an antifolate antibacterial agent that inhibits bacterial dihydrofolate reductase (DHFR), a critical enzyme that catalyzes the formation of tetrahydrofolic acid (THF) - in doing so, it prevents the synthesis of bacterial DNA and ultimately continued bacterial survival.[L11893] Trimethoprim is often used in combination with [sulfamethoxazole] due to their complementary and synergistic mechanisms but may be used as a monotherapy in the treatment and/or prophylaxis of urinary tract infections.[L11893,L11830] It is structurally and chemically related to [pyrimethamine], another antifolate antimicrobial used in the treatment of plasmodial infections.[T707]
Sulfamethoxazole and Trimethoprim for Injection, USP
Sulfatrim DS
Trisulfa S Suspension
Riva-sep DS
Sulfamethoxazole and Trimethoprim (Double Strength)
Polytrim Ophthalmic Solution
Proloprim 200 Tab 200mg
Coptin Oral Suspension
Teva-trimel
Sulfamethoxazole and Trimethoprim DS
Teva-trimel DS
Bactrim DS
Bactrim Roche Suspension Paediatric
PMS-polytrimethoprim
Primsol
SULFAMETHOXAZOLE and TRIMETHOPRIM
Trimethoprim
Septra DS Tablets
Roubac Tab 160/800
Sulfamethoxazole and Trimethoprim Tablets
Trimethoprim Tablets
Trisulfa Tab
Polymyxin B Sulfate and Trimethoprim
Proloprim
Nu-cotrimox Sus 40/8mg/ml
Coptin Tab
sulfamethoxazole-trimethoprim (SMZ)
TRIMPEX trimethoprim hydrochloride
Bactrim Roche Tab
Nu-cotrimox-DS Tab 800/160mg
Bactrim DS Roche Tab
Roubac Tab 80/400
Trimethoprim sulfate and Polymyxin B sulfate
Sulfamethoxazole and Trimethoprim Injection, BP
Sulfatrim Pediatric
SULFAMETHOXAZOLE AND TRIMETHOPRIM double strength
Bactrim
Septra DS
Protrin Df Tab
Septra Grape
Bactrim Roche Inj
Sandoz Polytrimethoprim
Nu-cotrimox Tab 400/80mg
Sulfamethox-TMP DS
POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE
Septra
Polymyxin B Sulfate and Trimethoprim Sulfate
Indication
As a monotherapy, trimethoprim is indicated for the treatment of acute episodes of uncomplicated urinary tract infections caused by susceptible bacteria, including _E. coli._, _K. pneumoniae_, _Enterobacter spp._, _P. mirabilis_, and coagulase-negative _Staphylococcus_ species.[L11893,L11890] In various formulations in combination with [sulfamethoxazole], trimethoprim is indicated for the following infections caused by bacteria with documented susceptibility: urinary tract infections, acute otitis media in pediatric patients (when clinically indicated), acute exacerbations of chronic bronchitis in adults, enteritis caused by susceptible _Shigella_, prophylaxis and treatment of _Pneumocystis jiroveci_ pneumonia, and travelers' diarrhea caused by enterotoxigenic _E. coli_.[L11830,L11863] Trimethoprim is available as an ophthalmic solution in combination with [polymyxin B] for the treatment of acute bacterial conjunctivitis, blepharitis, and blepharoconjunctivitis caused by susceptible bacteria.[L11887]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
